Hennion & Walsh Asset Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.97M Sell
93,021
-12,885
-12% -$700K 0.11% 232
2026
Q1
$6.65M Buy
105,906
+2,317
+2% +$185K 0.22% 96
2025
Q4
$9.88M Sell
103,589
-4,121
-4% -$404K 0.34% 53
2025
Q3
$10.5M Sell
107,710
-1,439
-1% -$149K 0.38% 41
2025
Q2
$11.7M Sell
109,149
-5,691
-5% -$576K 0.47% 31
2025
Q1
$11.6M Buy
114,840
+7,500
+7% +$755K 0.51% 30
2024
Q4
$9.59M Buy
107,340
+7,618
+8% +$671K 0.43% 38
2024
Q3
$8.35M Buy
99,722
+15,769
+19% +$1.24M 0.39% 40
2024
Q2
$6.47M Buy
83,953
+6,737
+9% +$493K 0.33% 53
2024
Q1
$5.29M Buy
77,216
+10,532
+16% +$677K 0.28% 69
2023
Q4
$3.86M Buy
66,684
+14,924
+29% +$797K 0.22% 112
2023
Q3
$2.73M Buy
51,760
+20,079
+63% +$1.05M 0.17% 156
2023
Q2
$1.71M Buy
31,681
+15,350
+94% +$802K 0.1% 241
2023
Q1
$817K Buy
16,331
+11,279
+223% +$532K 0.05% 403
2022
Q4
$234K Sell
5,052
-197
-4% -$8.53K 0.01% 701
2022
Q3
$203K Buy
+5,249
New +$211K 0.01% 715

Other funds holding BSX